doi: 10.1016/j.dsx.2023.102759
In the drugs best showing so far, the ATTAIN-1 trial, people taking orforglipron lost on average 12.4% of their baseline weight, a notch below the roughly 14% weight loss seen in similar trials of Novo Nordisks injectable Wegovy and also below the typical results seen with Eli Lillys tirzepatide, a dual GLP-1/GIP medication
This strategy may improve subjective tolerability for some individuals, especially during the titration phase when side effects are often most pronounced
This ingredient hasnt been shown in studies to feed fungal acne yeast
4.3 Anti-microbial activity of bee pollen The extracts of both BP and bee bread possess anti-bacterial activity toward gram-positive bacteria and gram-negative bacteria
Low-grade chronic inflammation is now known to be a major contributor to a myriad of conditions, including cancer, obesity and diabetes (Underwerth)